Malnutrition and nutrition support in COVID-19: The results of a nutrition support protocol.


Journal

Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 21 10 2020
accepted: 29 12 2020
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 6 1 2022
Statut: ppublish

Résumé

COVID-19 is characterized by various clinical manifestations, mainly respiratory involvement. Disease-related malnutrition is associated with impaired respiratory function and increased all-cause morbidity and mortality. Patients with COVID-19 infection carry a high nutritional risk. After designing a specific nutritional support protocol for this disease, we carried out a retrospective study on malnutrition and on the use of nutritional support in patients with COVID-19. We performed a retrospective study to determine whether nutritional support positively affected hospital stay, clinical complications, and mortality in patients with COVID-19. We compared the results with those of standard nutritional management. Our secondary objectives were to determine the prevalence of malnutrition in patients with COVID-19 and the value of nutritional support in the hospital where the study was performed. At least 60% of patients with COVID-19 experience malnutrition (up to 78.66% presented at least 1 of the parameters studied). The specialized nutritional support protocol was indicated in only 21 patients (28%) and was started early in only 12 patients (16%). Hospital stay was significantly shorter in patients managed with the early protocol (5.09 days, 95% CI, 1.338-8.853, p<0.01). Similarly, in this group, respiratory distress was less severe and less frequent (41% vs 82.5%, p<0.007), and statistically significantly fewer complications were recorded (9/12 vs 91/63; p<0.001). COVID-19 is associated with high rates of disease-related malnutrition. Early implementation of a specialized nutritional support plan can improve the prognosis of these patients by reducing hospital stay, the possibility of more severe respiratory distress, and complications in general.

Identifiants

pubmed: 34906342
pii: S2530-0180(21)00126-8
doi: 10.1016/j.endien.2021.11.019
pmc: PMC8665355
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-627

Informations de copyright

Copyright © 2021 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Références

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003288
pubmed: 19370584
Clin Nutr. 2011 Aug;30(4):484-9
pubmed: 21376433
Mil Med Res. 2020 Feb 6;7(1):4
pubmed: 32029004
Front Cell Infect Microbiol. 2018 Oct 08;8:343
pubmed: 30349811
Nutrients. 2020 Sep 27;12(10):
pubmed: 32992538
Support Care Cancer. 2016 Jan;24(1):429-435
pubmed: 26099900
Endocrinol Nutr. 2016 Jan;63(1):27-31
pubmed: 26476963
Lancet. 2019 Jun 8;393(10188):2312-2321
pubmed: 31030981
Ageing Res Rev. 2005 Aug;4(3):422-50
pubmed: 16081325
Clin Nutr. 1999 Feb;18(1):23-7
pubmed: 10459081
Clin Nutr ESPEN. 2020 Dec;40:214-219
pubmed: 33183539
Med Clin (Barc). 2009 Mar 21;132(10):377-84
pubmed: 19268323
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001880
pubmed: 20091525
Nutr Hosp. 2012 Jul-Aug;27(4):1049-59
pubmed: 23165541
Clin Nutr. 1995 Dec;14(6):336-40
pubmed: 16843954
Eur J Clin Nutr. 2020 Jun;74(6):871-875
pubmed: 32322046
Chest. 2016 Feb;149(2):526-534
pubmed: 26203671
Ageing Res Rev. 2012 Apr;11(2):278-96
pubmed: 22212388
Med Clin (Barc). 2017 Apr 7;148(7):303-307
pubmed: 27993414

Auteurs

Jesús Manuel Morán-López (JM)

Endocrinology and Nutrition, Hospital Virgen del Puerto (Plasencia), Sociedad Extemeña de Diabetes, Endocrinología y Nutrición, Spain. Electronic address: jesusmoranlopez@yahoo.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH